3440.10 with Changes - Navy Medicine - U.S. Navy

More documents

Recommendations

Info

Table 8 Tiered CPC Allotment: Pharmaceutical Countermeasures Tier 1 Tier 2 Tier 3 Ciprofloxacin (500 mg, tab) 330 250 200 Doxycycline (100 mg cap) 2,920 2,250 1,800 ATNAA(ea) 975 750 600 CANA(ea) 325 250 200 KI (130 mg tab, 14 per pg) 325 250 200 FHP EMP Standard 10: Exercise and Evaluation Tier 4 150 1,350 450 150 150 BUMEDINST 3440.10 CH-l 12 Dec 2011 Comments - 10% ofBIO Allotment (90/10 Doxy/ Cipro Split) - number of 5-day courses (500 mg, twice daily (BID), X 5 days = 10 Tabs per responder per course) - 90% of BIO Allotment (9011 0 Doxy/ Cipro Split) - number of 5-day courses (100 mg BID X 5 days = 10 Tabs per responder per course) - three injectors per first responder/ receiver - one injector per first responder/ receiver - all first responders/receivers will be 18 years old (or older) 1. To meet the requirements of references (a), (b), (e), (0), (q), and (r) of this section, MTFs and other designated Bureau of Medicine and Surgery activities must actively participate in Navy regional and installation level EM related training, to include regional and/or local table top exercise, command post exercise/functional exercise, and functional training exercise/full scale exercise. Additionally, MTFs shall also participate in appropriate local community EM related exercises, in close coordination with their respective Navy Medicine regional commander. 23 Enclosure (2)
BUMEDINST 3440.10 20 Nov 2008 2. MTFs shall participate in the exercise planning process with the region, installation, and civilian community to provide medically relevant exercise play that will contribute to enhanced EM interoperability, communications, and overall readiness. 3. MTFs shall generate written AARs to capture lessons learned for future use. AARs shall be maintained for a minimum of 2 years or until the next Joint Commission/Medical Inspector General visit (whichever is longer). A copy of the AAR shall be forwarded to the respective NAVMEDREG. The region will then forward the AAR to BUMED-M3/5 which is responsible for coordination with NOMI. 4. Exercise scenarios should consider the full spectrum of possible hazards and meet requirements set forth by reference (m) of this section. 5. When an MTF has responded to an actual event of appropriate magnitude, the respective NAVMEDREG may exempt the MTF from participation in exercises for a period of 6-12 months. FHP EMP Standard 11: Mitigation and Prevention 1. The Navy Medicine FHP EMP establishes mitigation and prevention standards and tools for use by MTF commanders in support of both MTF and installation operations. 2. MTFs shall assist in the processes through which mitigation efforts may diminish the effects of identified natural and man-made hazards. Such assistance will include providing initial site survey as well as risk assessment assistance following an incident, as well as granting approval for re-entry and making recommendations for proper and effective respiratory/personnel protection for first responders/receivers. 3. Where the capability exists, MTFs shall assist in the identification and confirmation of disease agents, and the prevention and/or mitigation of morbidity and mortality related to any all-hazards event. MTFs shall maintain a system and process for collecting, analyzing, and reporting installation population health that is sensitive to significant fluctuations in normal disease rates, and is coordinated with regional and local civilian public health surveillance systems. Those epidemiological investigative services will include and interact with clinical, environmental health, criminal/forensic services, as well as the surveillance of animal health, potable water and food, and air quality. In addition, MTFs shall maintain the capability to investigate and establish whether an infectious disease outbreak is occurring, and develop a case definition for victims of the outbreak. 4. In the event of an actual disease outbreak or CBRNE event, MTFs shall utilize their cache of CPCs and Medical Emergency Response Pharmaceuticals (MERP) to support designated Category 1 and 5 personnel as well as the general installation population. Furthermore, MTFs shall provide dispensing and/or immunizing teams to screen and educate patients, dispense pharmaceuticals, and provide post-exposure immunizations. In addition, MTFs shall be prepared 24 Enclosure (1)
Page 2: DEPARTMENT OF THE NAVY BUREAU OF ME
Page 5 and 6: BUMEDINST 3440.10 20 Nov 2008 stres
Page 7 and 8: BUMEDINST 3440.10 20 Nov 2008 d. Th
Page 10 and 11: NAVY MEDICINE FORCE HEALTH PROTECTI
Page 12 and 13: FHP EMP Standard 1: Program Managem
Page 14 and 15: BUMEDINST 3440.10 20 Nov 2008 3. BU
Page 16: Table 2. NA VMEDREG East MTF Tier D
Page 20 and 21: Table 4. NA VMEDREG NCA MTF Tier De
Page 22 and 23: BUMEDINST 3440.10 20 Nov 2008 (1) M
Page 24 and 25: BUMEDINST 3440.10 20 Nov 2008 shoul
Page 26 and 27: BUMEDINST 3440.10 20 Nov 2008 b. Op
Page 28 and 29: BUMEDINST 3440.10 CH-l 12 Dec 2011
Page 30 and 31: d. Biological Detection Capability
Page 34 and 35: BUMEDINST 3440.10 20 Nov 2008 to de
Page 36 and 37: BUMEDINST 3440.10 20 Nov 2008 SECTI
Page 38 and 39: BUMEDINST 3440.10 20 Nov 2008 Examp
Page 40 and 41: e. Preparedness Exercises BUMEDINST
Page 42 and 43: SECTION 3 COMMAND AND CONTROL Ref:
Page 44 and 45: BUMEDINST 3440.10 20 Nov 2008 SECTI
Page 46 and 47: SECTION 5 NAVY MEDICINE EMP EMO COM
Page 48 and 49: BUMEDINST 3440.10 20 Nov 2008 39 En
Page 50 and 51: SECTION 6 PROCEDURES FOR REQUESTING
Page 52 and 53: Element 1 Element 2 Element 3 Eleme
Page 54 and 55: Waiver Request in case of Naval Bra
Page 56 and 57: BUMEDINST 3440.10 CH-2 25 Apr2012 L
Page 58 and 59: BUMEDINST 3440.10 CH-2 25 Apr 2012
Page 60 and 61: BUMEDINST 3440.10 20 Nov 2008 EOC E
Page 62: SEL Selected Equipment List SME Sub

3440.10 with Changes - Navy Medicine - U.S. Navy

Create successful ePaper yourself

Delete template?

Save as template?